Skip to main content

Table 4 Associations among serum miR-21 expression and clinicopathological parameters in ovarian cancer patients

From: Evaluation of miRNA-21 and CA-125 as a promising diagnostic biomarker in patients with ovarian cancer

 

miR-21 expression

Mean ± SD

p

Age

 ≤ 50

5.92 ± 1.9

0.24

 > 50

5.29 ± 1.84

 

Residence

Rural

5.79 ± 1.7

0.27

Urban

5.2 ± 2.1

 

Family history

 − ve

5.18 ± 1.57

0.002*

 + ve

7.17 ± 2.3

 

FIGO stage

I/II

4.46 ± 1.13

 < 0.001*

III/IV

7.16 ± 1.57

 

Histological subtypes

Serous

4.1 ± 0.72

 < 0.001*

Mucinous

5.5 ± 1.67

 

Endometrioid

7.6 ± 1.06

 

US

Bilateral

5.7 ± 2.02

 

Multilocular

4.5 ± 0.6

0.09

Solid

6.58 ± 2.1

 
  1. *p < 0.05 when compared with control